Small bowel adenocarcinoma: Understaged and undertreated?

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2728-2732

  Nicholl, Michael B ^a   Ahuja, Vanita ^a   Conway, W Charles ^a   Vu, Vu D ^a   Sim, Myung Shin ^a   Singh, Gagandeep ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC ERROR; FEMALE; HUMAN; ILEUM CANCER; JEJUNUM CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SMALL BOWEL ADENOCARCINOMA; SMALL INTESTINE CARCINOMA;

AGED; HUMANS; INTESTINAL NEOPLASMS; INTESTINE, SMALL; LYMPH NODES; MIDDLE AGED; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 78049473298     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1109-x     Document Type: Article

References (33)

1. JS Chow CC Chen H Ahsan AI Neugut 1996 A population-based study of the incidence of malignant small bowel tumours: SEER, 1973-1990 Int J Epidemiol. 25 722 728 1:STN:280:DyaK2s%2FnvFOgtQ%3D%3D 10.1093/ije/25.4.722 8921448
2. T Haselkorn AS Whittemore DE Lilienfeld 2005 Incidence of small bowel cancer in the United States and worldwide: geographic, temporal, and racial differences Cancer Causes Control. 16 781 787 10.1007/s10552-005-3635-6 16132788
3. RK Ross NM Hartnett L Bernstein BE Henderson 1991 Epidemiology of adenocarcinomas of the small intestine: Is bile a small bowel carcinogen? Br J Cancer. 63 143 145 1:STN:280:DyaK3M7htlCqtw%3D%3D 1989654
4. TJ Wu CN Yeh TC Chao YY Jan MF Chen 2006 Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis World J Surg. 30 391 398 10.1007/s00268-005-7898-6 16479330 discussion 399
5. T Delaunoit F Neczyporenko PJ Limburg C Erlichman 2004 Small bowel adenocarcinoma: a rare but aggressive disease Clin Colorectal Cancer. 4 241 248 10.3816/CCC.2004.n.023 15555205 discussion 249-51
6. JR Howe LH Karnell HR Menck C Scott-Conner 1999 The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995 Cancer 86 2693 2706 1:STN:280:DC%2BD3c%2Fmt1Gnuw%3D%3D 10.1002/(SICI)1097-0142(19991215) 86:12<2693::AID-CNCR14>3.0.CO;2-U 10594865
7. A Jemal R Siegel E Ward T Murray J Xu C Smigal, et al. 2006 Cancer statistics, 2006 CA Cancer J Clin. 56 106 130 10.3322/canjclin.56.2.106 16514137
8. DL Ciresi DJ Scholten 1995 The continuing clinical dilemma of primary tumors of the small intestine Am Surg. 61 698 702 1:STN:280:DyaK2MzksVWjuw%3D%3D 7618809 discussion 702-3
9. F Laurent M Raynaud JM Biset M Boisserie-Lacroix P Grelet J Drouillard 1991 Diagnosis and categorization of small bowel neoplasms: role of computed tomography Gastrointest Radiol. 16 115 119 1:STN:280:DyaK3M3gtVGlsQ%3D%3D 10.1007/BF01887323 2016021
10. KJ Mitchell ES Williams LD Leffall Jr 1995 Primary malignant small bowel tumors: an atypical abdominal emergency J Natl Med Assoc. 87 276 279 1:STN:280:DyaK2M3ntFOisw%3D%3D 7752280
11. JA DiSario RW Burt H Vargas WP McWhorter 1994 Small bowel cancer: epidemiological and clinical characteristics from a population-based registry Am J Gastroenterol. 89 699 701 1:STN:280:DyaK2c3is1WjsQ%3D%3D 8172140
12. P Lambert A Minghini W Pincus P Kolm RR Perry 1996 Treatment and prognosis of primary malignant small bowel tumors Am Surg. 62 709 715 1:STN:280:DyaK28zltVWmsg%3D%3D 8751760
13. JB O'Connell MA Maggard JH Liu DA Etzioni CY Ko 2004 A report card on outcomes for surgically treated gastrointestinal cancers: are we improving? J Surg Res. 121 214 221 10.1016/j.jss.2004.04.002 15501461
14. J Cao Y Zuo F Lv Z Chen J Li 2008 Primary small intestinal malignant tumors: survival analysis of 48 postoperative patients J Clin Gastroenterol. 42 167 173 10.1097/01.mcg.0000248014.78020.7a 18209587
15. MK Gibson CA Holcroft LK Kvols D Haller 2005 Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma Oncologist. 10 132 137 1:CAS:528:DC%2BD2MXis1Kntrw%3D 10.1634/theoncologist.10-2-132 15709215
16. H Nelson N Petrelli A Carlin J Couture J Fleshman J Guillem, et al. 2001 Guidelines 2000 for colon and rectal cancer surgery J Natl Cancer Inst. 93 583 596 1:STN:280:DC%2BD3M3hvFejtg%3D%3D 10.1093/jnci/93.8.583 11309435
17. SL Chen AJ Bilchik 2006 More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study Ann Surg. 244 602 610 16998369
18. JM Mammen LE James M Molloy A Williams CJ Wray JJ Sussman 2007 The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry Am J Surg. 194 349 354 10.1016/j.amjsurg.2006. 08.092 17693281
19. VL Tsikitis DL Larson BG Wolff G Kennedy N Diehl R Qin, et al. 2009 Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved J Am Coll Surg. 208 42 47 10.1016/j.jamcollsurg.2008.10.013 19228501
20. C Locher D Malka V Boige P Lebray D Elias P Lasser, et al. 2005 Combination chemotherapy in advanced small bowel adenocarcinoma Oncology. 69 290 294 1:CAS:528:DC%2BD2MXht1Oqt7vJ 10.1159/000089678 16282708
21. P Stammberger K Baczako 1999 Cytokeratin 19 expression in human gastrointestinal mucosa during human prenatal development and in gastrointestinal tumours: relation to cell proliferation Cell Tissue Res. 298 377 381 1:STN:280:DC%2BD3c%2FjsF2jtw%3D%3D 10.1007/s004419900085 10571127
22. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, et al. AJCC cancer staging manual. 6th ed. Chicago, IL: Springer; 2002.
23. M Veyrieres P Baillet JM Hay A Fingerhut JL Bouillot M Julien 1997 Factors influencing long-term survival in 100 cases of small intestine primary adenocarcinoma Am J Surg. 173 237 239 1:STN:280:DyaK2s3ks1Gmsg%3D%3D 10.1016/S0002-9610(97)89599-2 9124635
24. NA Abrahams A Halverson VW Fazio LA Rybicki JR Goldblum 2002 Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors Dis Colon Rectum. 45 1496 1502 10.1007/s10350-004-6457-9 12432298
25. S Agrawal EC McCarron JF Gibbs HR Nava GE Wilding A Rajput 2007 Surgical management and outcome in primary adenocarcinoma of the small bowel Ann Surg Oncol. 14 2263 2269 10.1245/s10434-007-9428-2 17549572
26. BL Brucher JD Roder U Fink HJ Stein R Busch JR Siewert 1998 Prognostic factors in resected primary small bowel tumors Dig Surg. 15 42 51 1:STN:280:DyaK1M%2Fmt1Squw%3D%3D 10.1159/000018585 9845562
27. BS Dabaja D Suki B Pro M Bonnen J Ajani 2004 Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients Cancer. 101 518 526 10.1002/cncr.20404 15274064
28. MA Maggard I Yermilov JS Tomlinson CY Ko 2009 Are 12 nodes needed to accurately stage T1 and T2 colon cancers? Dig Dis Sci. 54 640 647 1:CAS:528:DC%2BD1MXht1Ontrc%3D 10.1007/s10620-008-0373-0 18612817
29. SL Wong H Ji BK Hollenbeck AM Morris O Baser JD Birkmeyer 2007 Hospital lymph node examination rates and survival after resection for colon cancer JAMA. 298 2149 2154 1:CAS:528:DC%2BD2sXhtlSksbrN 10.1001/jama.298.18.2149 18000198
30. PN Fishman GR Pond MJ Moore A Oza RL Burkes LL Siu, et al. 2006 Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases Am J Clin Oncol. 29 225 231 1:CAS:528:DC%2BD28XmsVKjsrk%3D 10.1097/01. coc.0000214931.01062.01 16755174
31. J Capdevila E Elez S Peralta T Macarulla FJ Ramos J Tabernero 2008 Oxaliplatin-based chemotherapy in the management of colorectal cancer Expert Rev Anticancer Ther. 8 1223 1236 1:CAS:528:DC%2BD1cXhtVWgu7zK 10.1586/14737140.8.8. 1223 18699761
32. DG Haller 2004 Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers Semin Oncol. 31 10 16 1:CAS:528:DC%2BD2MXhsVaqs7k%3D 10.1053/j.seminoncol.2004.11.006 15726529
33. MJ Overman S Kopetz S Wen PM Hoff D Fogelman J Morris JL Abbruzzese JA Ajani RA Wolff 2008 Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma Cancer. 113 2038 2045 1:CAS:528:DC%2BD1cXht12lurfL 10.1002/cncr.23822 18759326